A genetic variation, found predominantly in African Americans, protects some people with heart failure, enabling them to live longer than expected.

Researchers found that the genetic variation acts just like beta-blockers, a class of drugs used to treat chronic heart failure.

The researchers say their discovery adds to the accumulating evidence that genetic differences contribute to the way people respond to medications.